NCT05828446View on ClinicalTrials.gov

Improving Hepatocellular Carcinoma Screening

NARecruitingINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions
Magnetic Resonance ImagingHepatocellular CarcinomaScreeningContrast-enhanced US
Interventions
DEVICE

MRI

To compare the diagnostic performance of US+/- Constrast-enhanced US and AMRI for HCC detection in an at-risk population

Trial Locations (1)

1011

RECRUITING

Lausanne University Hospital, Lausanne

All Listed Sponsors
lead

Naik Vietti Violi

OTHER